scholarly article | Q13442814 |
P2093 | author name string | M Farooqui | |
H Alhamdan | |||
K Alsaad | |||
N Aloudah | |||
P2860 | cites work | Response of type I membranoproliferative glomerulonephritis to pulse methylprednisolone and alternate-day prednisone therapy | Q71951418 |
Effect of aspirin and dipyridamole on proteinuria in idiopathic membranoproliferative glomerulonephritis: a multicentre prospective clinical trial. Collaborative Glomerulonephritis Therapy Study Group (CGTS) | Q72829904 | ||
Recurrence of type I membranoproliferative glomerulonephritis after renal transplantation: analysis of the incidence, risk factors, and impact on graft survival | Q73445498 | ||
Frequency of primary glomerular disease in northeastern China | Q84583966 | ||
Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood--follow-up after CD19 recovery | Q84654866 | ||
Non-infectious pulmonary complications of newer biological agents for rheumatic diseases--a systematic literature review | Q31039549 | ||
Pattern of biopsy-proven renal disease in a single center of south India: 19 years experience | Q35351264 | ||
Glomerular diseases in the Military Hospital of Morocco: Review of a single centre renal biopsy database on adults. | Q36391014 | ||
Posttransplant recurrence of primary glomerulonephritis | Q37804640 | ||
Our experience with rituximab therapy for adult-onset primary glomerulonephritis and review of literature. | Q38026511 | ||
Clinicopathological features of childhood nephrotic syndrome in Saudi Arabia | Q38856560 | ||
Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis | Q40144637 | ||
Interstitial pneumonitis during rituximab-containing chemotherapy for non-Hodgkin lymphoma | Q40409474 | ||
Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR). | Q41693630 | ||
Combination therapy with mycophenolate mofetil and prednisone in steroid-resistant idiopathic membranoproliferative glomerulonephritis. | Q43085129 | ||
Prognostic factors in mesangioproliferative glomerulonephritis | Q44116235 | ||
Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry. | Q44726792 | ||
Remission of resistant MPGN type I with mycophenolate mofetil and steroids | Q45084031 | ||
Recurrence of membranoproliferative glomerulonephritis type II in renal allografts: The North American Pediatric Renal Transplant Cooperative Study experience | Q46486094 | ||
Rituximab therapy for Type I membranoproliferative glomerulonephritis. | Q51395552 | ||
Use of anti-CD20 antibody in the treatment of post-transplant glomerulonephritis | Q59644719 | ||
Membranoproliferative Glomerulonephritis Type I in Renal Transplantation Patients: A Single-Center Study of a Cohort of 68 Renal Transplants Followed Up for 11 Years | Q60729392 | ||
Recurrent membranoproliferative glomerulonephritis after kidney transplantation | Q60976642 | ||
Effectiveness of pulse cyclophosphamide plus oral steroid therapy in idiopathic membranoproliferative glomerulonephritis | Q62085808 | ||
Results of a controlled drug trial in membranoproliferative glomerulonephritis | Q69889953 | ||
Pulse methylprednisolone therapy in children with membranoproliferative glomerulonephritis | Q70816465 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | membranoproliferative glomerulonephritis | Q2299379 |
rituximab | Q412323 | ||
glomerulonephritis | Q605006 | ||
P304 | page(s) | 823-826 | |
P577 | publication date | 2015-04-01 | |
P1433 | published in | Transplantation Proceedings | Q7834825 |
P1476 | title | Treatment-resistant recurrent membranoproliferative glomerulonephritis in renal allograft responding to rituximab: case report | |
P478 | volume | 47 |
Q39009557 | Chronic allograft injury: Mechanisms and potential treatment targets |
Q38795065 | Current pathological perspectives on chronic rejection in renal allografts |
Q48256943 | Diseases of complement dysregulation-an overview |
Q93047764 | Recurrent and de novo Glomerulonephritis After Kidney Transplantation |
Q38749694 | Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies |
Search more.